Kezar Life Sciences, Inc. - KZR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 06, 2026 | SCHEDULE 13G | Baselake Partners, LP | 5.3% | 391,862 | View |
| Apr 06, 2026 | SCHEDULE 13G | Baselake Management, LLC | 5.3% | 391,862 | View |
| Apr 06, 2026 | SCHEDULE 13G | David Paolella | 5.3% | 391,862 | View |
| Apr 01, 2026 | SCHEDULE 13D/A | — | 100.0% | — | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Stonepine Capital Management, LLC | 2.1% | 156,179 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Stonepine Capital, L.P. | 2.1% | 156,179 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Stonepine GP, LLC | 2.1% | 156,179 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Jon M. Plexico | 2.1% | 156,179 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | BML Investment Partners, L.P. | 9.8% | 720,787 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Partners Management LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Partners Management (GP) LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Capital Partners Fund (GP) LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Capital Partners (GP) LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Master Fund LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Michael Gregory | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.